New research from the University of California, San Diego, suggests that statins may offer protection beyond lowering cholesterol. According to the study, glaucoma patients who use these medications seem to have a lower chance of needing surgery and might experience a slower progression of their condition. Glaucoma, often called the “silent thief of sight,” can result in blindness if untreated as it harms the optic nerve that carries visual signals to the brain.
The study, which appears in the British Journal of Ophthalmology, indicates that glaucoma patients taking statins are less likely to require stronger treatments, such as additional eye drops or surgical procedures. Dr. Robert Weinreb, the study’s author, noted that while statins are mainly prescribed for cholesterol management, there is evidence suggesting they may also help prevent or slow the death of nerve cells. However, their exact impact on glaucoma, a major cause of irreversible blindness, is not well understood.
Dr. Weinreb’s team examined a comprehensive global database that included data from 165 million individuals. They compared over 210,000 patients with a history of statin use from 2006 to 2026 with a similar group of 210,000 who did not use statins. All individuals had recorded follow-ups with eye specialists. The results showed that those on statins had a reduced likelihood of progressing to surgery or needing additional treatments for glaucoma.
Specifically, the findings revealed that: – Statin users had a 15% lower risk of developing the most common form of glaucoma. – After five years, there was a 36% lower risk of requiring incisional glaucoma surgery and a 55% lower risk of needing minimally invasive glaucoma surgery (MIGS), a procedure aimed at reducing intraocular pressure. – Statins were also linked to a 60% lower risk of undergoing selective laser trabeculoplasty (SLT), which uses lasers to decrease eye pressure. – Additionally, there was a 12% reduced risk of needing eye drops to manage eye pressure among those taking statins.
After ten years, statin use continued to show lower risks for incisional glaucoma surgery, MIGS, SLT, and the need for eye drops. In a separate analysis, researchers looked at over 30,000 glaucoma patients taking statins and compared them with nearly 250,000 who were not on the medication. While these studies are observational and do not establish direct cause and effect, they contribute to the growing body of research on the neuroprotective qualities of statins.
What do you think about the potential benefits of statins for glaucoma?
Sources:
Source: Good News Network, by Good News Network